Searched for
AUROBINDO PHARMA TRADING UPDATE
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next weekSBI Securities expects Nifty's breakout to strengthen if it crosses 24,450, opening the door to 24,900. While small-caps continue outperfor...- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Dabur Q1 updates: Co expects double-digit revenue growth as rural demand stays ahead of urbanDabur India anticipates a significant boost in its first-quarter profit, driven by strategic price hikes that effectively countered rising ...
- IT selling nearing an end; banks and FMCG remain top bets: Neeraj DewanBroader markets show resilience despite IT sector weakness, with expert Neeraj Dewan suggesting investor confidence hinges on stronger comp...
- Nifty eyes 25,000 as July rally builds; banking, realty and auto lead the charge: Rohit SrivastavaMarket strategist Rohit Srivastava anticipates a strong summer for Indian equities, with the Nifty poised for gains. He highlights banking,...
- Market Trading Guide: TBO Tek among 2 stock recommendations for ThursdayDomestic equities ended higher, supported by positive Asian cues and a sharp drop in crude prices following improved traffic at the Strait ...
- GMR Airports among 7 stocks hit 52-week highs, rally up to 20% in a monthSeven BSE 200 stocks, led by GMR Airports and FSN E-Commerce Ventures, scaled fresh 52-week highs despite a weak broader market, gaining up...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...
- Indian envoy holds talks with senior Chinese commerce ministry official on trade tiesIndian Ambassador Vikram Doraiswami met a senior Chinese Commerce Ministry official to boost trade and commercial cooperation. The discussi...
- Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthThe Sensex fell 372 points on Monday, but nine BSE Midcap stocks touched fresh 52-week highs, signalling resilient investor confidence. Ban...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Nifty has more room to run; stay selective: AnalystsIndian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommen...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
Load More
